BUZZ - Insmed shares fall as CFO Sara Bonstein resigns
路透社2026/10/05 11:46October 5 - ** Shares of pharmaceutical company Insmed (INSM.O) fell more than 3% in pre-market trading to $107.59. ** Sara Bonstein will resign from her position as Chief Financial Officer, effective October 30. ** Sara will stay on until the end of this month to ensure a smooth transition during the company's release of its Q3 financial results on October 29. ** Before joining Insmed, Sara served as Chief Financial Officer at OncoSec Medical. ** The company reaffirmed its fiscal 2026 performance guidance and has begun the search for the next Chief Financial Officer. ** All 25 brokerages covering the stock remain bullish; the median target price is compiled by LSEG data. ** As of the close of the previous trading day, the stock was down 36.15% year-to-date. (To assist non-English speakers, Reuters automatically translates its reports into several other languages. Because automated translations may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of the translated text and provides automated translation solely for reader convenience. Reuters accepts no liability for any damage or losses caused by the use of automated translation functionality.)
October 5 - ** The share price of pharmaceutical company Insmed (INSM.O) fell more than 3% in pre-market trading to $107.59
** Sara Bonstein will resign as Chief Financial Officer, effective October 30
** Sara will remain until the end of this month to ensure a smooth transition during the company's third quarter earnings release on October 29
** Prior to joining Insmed, Sara served as Chief Financial Officer of OncoSec Medical
** The company reaffirmed its fiscal year 2026 guidance and has begun the search for the next Chief Financial Officer
** All 25 brokerages covering the stock are bullish; the median target price — data compiled by LSEG
** As of the close of the last trading day, the stock was down 36.15% year-to-date
(To facilitate non-native English speakers, Reuters has automated the translation of its reports into several other languages. Because automated translation may contain errors or may lack necessary context, Reuters does not guarantee the accuracy of the automated translation text and provides it solely for the convenience of readers. Reuters assumes no liability for any damage or loss caused by the use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Buying Wind in the Cryptocurrency Market! Significant Activity in Bitcoin, Ethereum, and Solana! Here are the Details…
Hulamin says Paul Baloyi resigns as independent non-executive director
Hulamin said independent non-executive director Paul Baloyi resigned, effective Oct. 2, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hulamin Ltd. published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S604350), on October 05, 2026, and is solely responsible for the information contained therein.
US Stocks Move | RXO (RXO.US) surges nearly 23% in pre-market after being acquired by C.H. Robinson Logistics (CHRW.US) for $5.8 billions
C.H. Robinson Logistics (CHRW.US) has agreed to acquire trucking brokerage company RXO (RXO.US) for approximately $5.8 billions, aiming to strengthen the logistics operations of the merged company.
